Dilip S Shanghvi
Chairman & Managing Director
Mr. Dilip S. Shanghvi is a graduate in commerce from Calcutta University. He is the Chairman and Managing Director of Sun Pharmaceutical Industries Limited and founded that Company in 1982. He has extensive experience in the pharmaceutical industry. Mr. Shanghvi is actively involved in international pharmaceutical markets and research and development functions at SPARC Ltd.
Under the leadership of Mr. Dilip S. Shanghvi, Sun Pharmaceutical Industries Ltd. has recorded an all-round growth in the business.Dilip Shanghvi (born 1 October 1955) is an Indian businessman and one of the richest persons in India. He is the founder and managing director of Sun Pharmaceuticals.
As of the 2015 Forbes real time ranking, he is the richest Indian having surpassed the long-standing richest Indian on the list, Mukesh Ambani.Dilip was born in small town of Amreli[1] in Gujarat on 1 October 1955.Shanghvi earned a Bachelor of Commerce degree from the University of Calcutta. He is an alumnus ofJ. J. Ajmera High School and Bhawanipur Education Society College, from where he did his schooling and graduation, respectively.
He started by helping his father in the latter's wholesale generic drugs business in Kolkata.It was during his work as a drugs distributor at Kolkata, he thought of manufacturing his own drugs instead of selling others' products.
Dilip Shanghvi started Sun Pharmaceutical Industries with capital of Rs 10,000 in 1982 at Vapi. Shanghvi founded Sun Pharmaceuticals in 1983 with five psychiatry products. Today, it is India's largest drugmaker and most valuable drug company. Appreciation of Sun's stock led to a 50% surge in his personal wealth, amounting to USD 4.7 billion.As of August 2014, he has a net worth of $17.2 billion, according to the Bloomberg Billionaire's Index.
He has also been named in the list of Asia’s top ten wealthiest self-made billionaires, according to Wealth-X. Shanghvi is also the Chairman and Managing Director of Sun Pharma Advanced Research Company and Shantilal Shanghvi Foundation.
In 1997, he acquired Caraco Pharma, a loss-making American company, with the aim of expanding Sun's reach in the United States and turned them around in no time. Both the deals have paid off; the US now accounts for 60% of Sun's revenue. He also acquired Israel's Taro Pharma in 2007. He is also credited with steering Sun Pharma to fifth place in the global generic drugs market.
On 19 February 2015, he surpassed Mukesh Ambani as the richest person of India, as his parent company stocks surges.Mr. Dilip Shantilal Shanghvi Founded Sun Pharmaceutical Industries Limited in 1982 and served as its Managing Director since May 29, 2012. Mr. Shanghvi served as the Chairman and Managing Director of Sun Pharmaceutical Industries, Inc.
Mr. Shanghvi has been the Chairman and Managing Director of Sun Pharma Advanced Research Company Limited since March 1, 2007. He has wide extensive industrial experience in the Pharmaceutical industry. He has been the Chairman of Taro Pharmaceutical Industries Ltd., since July 18, 2013.
Mr. Shanghvi has been the Chairman of Caraco Pharmaceutical Laboratories Ltd. since 1997. He served as the Chairman of the Board of Sun Pharmaceutical Industries Ltd until May 28, 2012. since 1999. He served as the Chairman of Taro Pharmaceutical Industries Ltd. from September 20, 2010 to April 18, 2012
He serves as a Director at Sun Speciality Chemicals Pvt. Ltd., Sun Pharma Advanced Research Company Ltd, Sun Resins & Polymers Pvt. Ltd., Sun Fastfin Services Pvt. Ltd., Sun Petrochemicals Private Limited, SPARC Bio-Research Private Limited, Sun Pharma Global Inc., British Virgin Island, Sun Pharma De Mexico SA DE CV, SPIL De Mexico SA DE CV and Shantilal Shanghvi Foundation. He serves as its Promoter Executive Director of Sun Pharmaceutical Industries Ltd .
He served as a Director of Taro Pharmaceutical Industries Ltd. until April 18, 2012. Mr. Shanghvi is graduate in commerce from Kolkata University.